基斯乳化:克服免疫逃避和治疗耐药性的新目标
Fatemeh Ghadyani1, Pouyan Zandi2,3, Soudeh Ghafouri-Fard4
1Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Medical oncology (Northwood, London, England)
|August 2, 2025
概括
由癌症中乳酸盐积累所驱动的基因素乳化,通过改变瘤微环境,促进免疫逃避和治疗抵抗. 向乳化为新型癌症疗法提供了一个有希望的策略.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 代谢重编程是癌症的一个标志.
- 乳酸积累在瘤微环境中很常见.
- 表观遗传修饰,如基因组乳化,正在成为癌症进展的关键调节者.
研究的目的:
- 审查新出现的证据,关于质激素乳化在癌症中的作用.
- 探索乳化对瘤微环境 (TME),免疫逃避和治疗耐药性的影响.
- 为了确定潜在的治疗策略,以乳酸化为目标.
主要方法:
- 文献综述综合了关于癌症中基因素乳化的当前研究.
- 对乳化对免疫细胞 (巨细胞,T细胞) 和瘤转录的作用的分析.
- 评估尚未解决的问题和未来的研究方向.
主要成果:
- 乳化通过极化巨细胞和耗尽T细胞来重塑TME.
- 基斯乳酸化稳定瘤转录物,有助于癌症的进展.
- 乳糖化作为一种代谢传感器和免疫抑制的媒介.
结论:
- 基因组乳化是一种关键的表观遗传机制,将癌症代谢与免疫逃避和治疗耐药性联系起来.
- 向乳化途径为开发新型组合疗法提供了一个有希望的途径.
- 需要进一步的研究,以了解依赖于背景的乳化效应和与其他修饰的相互作用.
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cytotoxic T Cells-mediated Immune Response
2.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K
Histone Modification
14.0K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
14.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Chromatin Modification in iPS Cells
1.9K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.9K
Spreading of Chromatin Modifications
8.5K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.5K


